Why Cancer Immunotherapy Fails?: Mechanisms of Resistance and Emerging Reversal Strategies
Muhydeen Damilola Badru, Tobi Ayomide Lawal, Udeichi Nnenna Chidimma, Mayowa Josiah Badmus, Francis Esther Ene, Daniel Chinaza Anyirionye, Naomi Ngozichukwuka Ajoniloju, Adegbesan Abiodun Christopher & Comfort Mary Afolabi · Journal of Cancer and Tumor International · 2025
Cancer immunotherapy has revolutionized the field of oncology by enabling the immune system to target and destroy cancer cells. Therapies such as immune checkpoint inhibitors, including PD-1/PD-L1 and CTLA-4 blockade, and chimeric antigen receptor T (CAR-T) cells have shown unpre...
Open access
Research Article
10.9734/jcti/2025/v15i3306